Detalhe da pesquisa
1.
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab.
Ann Nucl Med;
36(3): 224-234, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35060071